Canada - English - Health Canada

pharmascience inc - prucalopride (prucalopride succinate) - tablet - 1mg - prucalopride (prucalopride succinate) 1mg - miscellaneous gi drugs

Canada - English - Health Canada

pharmascience inc - prucalopride (prucalopride succinate) - tablet - 2mg - prucalopride (prucalopride succinate) 2mg - miscellaneous gi drugs

Canada - English - Health Canada

apotex inc - prucalopride (prucalopride succinate) - tablet - 1mg - prucalopride (prucalopride succinate) 1mg - miscellaneous gi drugs

Canada - English - Health Canada

apotex inc - prucalopride (prucalopride succinate) - tablet - 2mg - prucalopride (prucalopride succinate) 2mg - miscellaneous gi drugs

Malta - English - Medicines Authority

medichem, s.a. fructuós gelabert 6-8, 08970, sant joan despí, (barcellona), spain - prucalopride succinate - film-coated tablet - prucalopride succinate 1 mg - drugs for constipation

Malta - English - Medicines Authority

medichem, s.a. fructuós gelabert 6-8, 08970, sant joan despí, (barcellona), spain - prucalopride succinate - film-coated tablet - prucalopride succinate 2 mg - drugs for constipation

Malta - English - Medicines Authority

holsten pharma gmbh hahnstraße 31-35 60528 frankfurt am main , germany - prucalopride succinate - film-coated tablet - prucalopride succinate 1 mg - drugs for constipation

Malta - English - Medicines Authority

holsten pharma gmbh hahnstraße 31-35 60528 frankfurt am main , germany - prucalopride succinate - film-coated tablet - prucalopride succinate 2 mg - drugs for constipation

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - prucalopride succinate, quantity: 1.321 mg (equivalent: prucalopride, qty 1 mg) - tablet - excipient ingredients: titanium dioxide; lactose monohydrate; macrogol 400; colloidal anhydrous silica; magnesium stearate; hypromellose; polysorbate 80; microcrystalline cellulose - prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief.,? before prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation.,? if treatment with prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - prucalopride succinate, quantity: 2.642 mg (equivalent: prucalopride, qty 2 mg) - tablet - excipient ingredients: microcrystalline cellulose; titanium dioxide; macrogol 400; colloidal anhydrous silica; lactose monohydrate; iron oxide red; hypromellose; magnesium stearate; polysorbate 80 - prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief.,? before prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation.,? if treatment with prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.